Table 2.
Baseline characteristics of the patients between two groups.
| Folate receptor- | Folate receptor+ | P value | |||
|---|---|---|---|---|---|
| Number | Rate | Number | Rate | ||
| Gender | 0.99 | ||||
| Male | 37 | 77.08 | 77 | 77 | |
| Female | 11 | 22.92 | 23 | 23 | |
| Age | 60 ± 5.57 | 58 ± 7.07 | 0.08 | ||
| Tumor local | 0.99 | ||||
| Upper | 3 | 6.25 | 6 | 6 | |
| Middle | 33 | 68.75 | 68 | 68 | |
| Lower | 12 | 25 | 26 | 26 | |
| Tumor size | 5.5 ± 2.17 | 5 ± 1.83 | 0.14 | ||
| pTNM stage | 0.21 | ||||
| 1 | 1 | 2.08 | 4 | 4 | |
| 2 | 25 | 52.09 | 34 | 34 | |
| 3 | 21 | 43.75 | 59 | 59 | |
| 4 | 1 | 2.08 | 3 | 3 | |
| Lymph node metastasis | 0.10 | ||||
| Negative | 22 | 45.83 | 32 | 32 | |
| Positive | 26 | 54.17 | 68 | 68 | |
| Differentiation grade | 0.69 | ||||
| Well | 29 | 60.42 | 60 | 60 | |
| Poor | 18 | 37.5 | 35 | 35 | |
| Undifferentiated | 1 | 2.08 | 5 | 5 | |
| Adjuvant chemotherapy | |||||
| Yes | 16 | 33.33 | 75 | 75 | 1.08E-06 |
| No | 32 | 66.67 | 25 | 25 | |